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The initial stages of neurodegeneration are commonly marked by normal levels of cognitive and motor performance despite the
presence of structural brain pathology. Compensation is widely assumed to account for this preserved behaviour, but despite the
apparent simplicity of such a concept, it has proven incredibly difﬁcult to demonstrate such a phenomenon and distinguish it from
disease-related pathology. Recently, we developed a model of compensation whereby brain activation, behaviour and pathology,
components key to understanding compensation, have speciﬁc longitudinal trajectories over three phases of progression. Here, we
empirically validate our explicit mathematical model by testing for the presence of compensation over time in neurodegeneration.
Huntington’s disease is an ideal model for examining longitudinal compensation in neurodegeneration as it is both monogenic and
fully penetrant, so disease progression and potential compensation can be monitored many years prior to diagnosis. We deﬁned our
conditions for compensation as non-linear longitudinal trajectories of brain activity and performance in the presence of linear
neuronal degeneration and applied our model of compensation to a large longitudinal cohort of premanifest and early-stage
Huntington’s disease patients from the multisite Track-On HD study. Focusing on cognitive and motor networks, we integrated
progressive volume loss, task and resting state functional MRI and cognitive and motor behaviour across three sequential phases of
neurodegenerative disease progression, adjusted for genetic disease load. Multivariate linear mixed models were ﬁtted and trajec-
tories for each variable tested. Our conceptualization of compensation was partially realized across certain motor and cognitive
networks at differing levels. We found several signiﬁcant network trends that were more complex than that hypothesized in our
model. These trends suggest changes to our theoretical model where the network effects are delayed relative to performance effects.
There was evidence of compensation primarily in the prefrontal component of the cognitive network, with increased effective
connectivity between the left and right dorsolateral prefrontal cortex. Having developed an operational model for the explicit
testing of longitudinal compensation in neurodegeneration, it appears that general patterns of our framework are consistent with
the empirical data. With the proposed modiﬁcations, our operational model of compensation can be used to test for both cross-
sectional and longitudinal compensation in neurodegenerative disease with similar patterns to Huntington’s disease.
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Introduction
Compensation is presumed to account for preserved behav-
iour in neurodegeneration during the initial stages of dis-
ease. Several studies have investigated this phenomenon
(Kloppel et al., 2009; Malejko et al., 2014; Dillen et al.,
2016; Jones et al., 2016; Poston et al., 2016; Pan et al.,
2017), but none used a consistent deﬁnition of compensa-
tion. Consequently, a range of possible compensatory
mechanisms has been proposed, often post hoc, including
increased task-network brain activity or unexpected activity
in an area not typically associated with performance of a
particular behaviour. Thus, it is unclear to what extent re-
ported changes in brain activity represent compensation or
simply reﬂect the deleterious effect of disease-related
pathology.
The lack of both a well-deﬁned characterization of com-
pensation and a corresponding model for empirical investi-
gation has resulted in only a partial understanding of the
nature of compensation in neurodegeneration. In response,
we developed a model that operationalizes compensation
providing a clearer and concise mathematical description
of compensation (Gregory et al., 2017). This model was
based on one theory of compensation in healthy ageing
whereby compensation is indexed by increased activation
within an existing network (Barulli and Stern, 2013). As
compensation occurs over time, we described a theoretical
framework in which brain activation, behavioural perform-
ance, and structural volume loss have speciﬁc longitudinal
trajectories over three phases of progression. Assuming that
structural disease load increases steadily throughout, our
model proposes that during the earliest phase, constant per-
formance is maintained by increased brain activation; in the
second phase, brain activation decreases as performance
levels begin to deteriorate; and in the ﬁnal stage, both
brain activation and performance levels decrease rapidly,
similar to brain volume. This verbal description is opera-
tionalized through statistical models, and evidence of com-
pensation for a particular dataset is evaluated with
parameter estimates and statistical tests.
Considering Huntington’s disease as our reference, spe-
ciﬁc longitudinal trajectory patterns are required for com-
pensation. A compensatory relationship is indexed by
longitudinal trajectories of brain activity and performance
that are non-linear, speciﬁcally concave-down (with respect
to the time axis), while structural disease load increases
linearly over time (this scenario assumes that lower values
of performance indicate greater deterioration). Our model
requires an extended epoch in order to increase the likeli-
hood that the non-linear trajectories will be observed (as
opposed to only observing the increase in activation in the
early stage, for example). In many observational longitu-
dinal studies, there is a wide range of ages at study entry,
which allows between-participant information to enhance
within-participant change. Our model allows leveraging
the combination of between- and within-participant
information to evaluate longitudinal patterns of
compensation.
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In this study, we present the ﬁrst empirical test of our
compensation model in a neurodegeneration cohort. We
consider both task functional MRI and resting state func-
tional MRI markers of potential compensation in a
Huntington’s disease cohort of premanifest (pre-HD) and
early Huntington’s disease patients. Huntington’s disease is
an ideal model for examining the nature of longitudinal
compensation in neurodegeneration because it is both
monogenic and fully penetrant caused by an expansion of
the CAG triplet repeat in the HTT gene (full penetrance for
CAG 5 40). There is a reliable genetic test for the
Huntington’s disease gene mutation expansion and so it
is possible to monitor disease progression and the onset
of compensation many years prior to motor diagnosis. To
anticipate our ﬁndings, we found evidence of motor com-
pensation in Huntington’s disease indexed by connectivity
between regions of the secondary motor cortex, but our
results motivate extensions to our model to fully character-
ize patterns of compensation.
Materials and methods
Participants
A total of n = 110 participants were recruited from the four
Track-On HD study sites (Kloppel et al., 2015). All partici-
pants had different initial levels of progression but were all
known Huntington’s disease gene mutation expansion carriers
(94 pre-HD and 16 early Huntington’s disease). All partici-
pants were followed for 36 months with up to three annual
visits (task functional MRI data were only collected for two
time points at all sites). Most pre-HD participants came from
the earlier Track-HD study (Tabrizi et al., 2013). Those re-
cruited speciﬁcally for the Track-On study were required to
have a CAG repeat length 5 40 and a disease burden score
(DBS) (Penney et al., 1997) 4250 at recruitment. Exclusion
criteria included manifest disease, age below 18 or above 65
(unless previously in the Track-HD study), major psychiatric,
neurological or medical disorder or a history of severe head
injury (for full details see Kloppel et al., 2015). For the statis-
tical analysis, there was up to 303 observations; 89 partici-
pants (81%) had three visits (repeated measurements), 15
(14%) had two visits, and six (5%) had one visit. Missing
data varied among variables, and the number of participants
and observations are noted for each analysis. Only right-
handed people were included in the analysis, and one clear
outlier was excluded who had almost the smallest brain
volume but was relatively young and had almost the shortest
CAG expansion. The study was approved by the local ethics
committees and all participants gave written informed consent
according to the Declaration of Helsinki.
Behavioural measures and functional
MRI tasks
For the resting state functional MRI analyses, a global cogni-
tive composite score was derived from nine cognitive tasks that
were completed in testing sessions separate to the MRI
procedures [Stroop Word Reading test, Symbol Digit
Modality Test, Paced Tapping, Circle Tracing (two condi-
tions), Map Search test, Cancellation task, the Spot the
Change task, Mental Rotation task] (for full details see
Kloppel et al., 2015). Based on the Track-HD study the
Uniﬁed Huntington’s Disease Rating Scale (UHDRS)-Total
Motor Score (TMS), and Quantitative Motor (Q-Motor)
Speeded Tapping were selected as markers of motor perform-
ance (for full information see Kloppel et al., 2015).
Participants also performed a Verbal Working Memory
(VWM) and Sequential Finger Movement (SFM) functional
MRI task in the scanner. For the VWM task, participants
performed a verbal n-back task with two levels of working
memory load (1-back and 2-back) whereby they were required
to respond according to whether the letter on screen was the
same as the letter presented one letter previously (1-back) or
presented two letters previously (2-back). Performance in the
1-back and 2-back conditions was analysed using the d-prime
coefﬁcient (probability of correct response minus probability of
false positive responses). For the SFM task, participants per-
formed a motor task that involved metronome-paced ﬁnger
tapping with their right (dominant) hand (see Kloppel et al.,
2015 for a detailed description). Mean timing inaccuracies
(cue-response intervals) and standard deviations for four con-
ditions comprising all permutations of complexity (simple/com-
plex) and speed (slow/fast) were included in the compensation
model as independent outcome variables for all task functional
MRI analyses. All motor variables were natural log trans-
formed to make their empirical distribution more symmetric.
Procedures and variable selections were identical to the cross-
sectional study on compensation (Kloppel et al., 2015).
MRI data acquisition
3T MRI data were acquired on two different scanner systems
(Philips Achieva at Leiden and Vancouver and Siemens TIM
Trio at London and Paris) as described for each of the three
visits (Tabrizi et al., 2013; Kloppel et al., 2015). For task and
resting state functional MRI, whole-brain volumes were
acquired at a repetition time of 3 s using a T2*-weighted echo
planar imaging (EPI) sequence with the following parameters:
echo time 30ms, ﬁeld of view 212mm, ﬂip angle 80, 48 slices
in ascending order (slice thickness: 2.8mm, gap: 1.5mm, in
plane resolution 3.3  3mm) and bandwidth of 1906Hz/Px.
For resting state functional MRI, 165 volumes were acquired
over 8:20min followed by ﬁeld map acquisition. Two hundred
and twenty-ﬁve volumes over 11:15min for the SFM task and
190 volumes over 9:30min of VWM task functional MRI data.
For the third visit due to the time constraints of the scanning
sessions, the tasks were each performed at only two sites:
the SFM task was performed at Vancouver and Leiden only;
the VWM back task was performed at Paris and London only.
The missing data were accounted for in our statistical
analyses (see below). Standardization of data acquisition
across sites was performed based on previous suggestions
(Kloppel et al., 2015).
MRI data processing
T1-weighted images were processed as described in Kloppel
et al. (2015). The brain disease load composite score was
derived from the segmentations of the structural MRI data
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and included whole brain grey matter, white matter, caudate
and putamen volumes (all corrected for total intracranial
volume). The volumes from all three time-points for each of
the four segmentations were included in a principal compo-
nents analysis with the resulting weights providing the basis
for the brain disease burden score. For further details see the
online Supplementary material.
Functional MRI data preprocessing and subsequent statis-
tical analyses were performed using SPM8 running under
MATLAB for each of the three visits (Kloppel et al., 2015).
The T1 scan was segmented into grey and white matter using
the VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm/) and
used to create an improved anatomical scan for coregistration.
Using the DARTEL extension, deformation parameters were
extracted for normalization of functional images (Ashburner
and Friston, 2011). The ﬁrst four EPI images were discarded
to allow for steady state equilibrium. Functional images were
ﬁrst realigned and ﬁeld maps used for inhomogeneity correc-
tion whenever available. For resting state functional MRI, all
EPI images were then coregistered to the new anatomical
image and normalized using DARTEL deformation param-
eters. For task functional MRI, only contrast images were
normalized and smoothed. Finally, data were smoothed using
a 6mm full-width at half-maximum Gaussian kernel. See our
previous study for a description of standardization and quality
control measures (Kloppel et al., 2015).
MRI data analysis
We performed task-based functional MRI analyses based on
preselected regions of interest identical to those used in the
resting state functional MRI analyses (see below). A ﬁrst-
level analysis based on the general linear model (GLM) was
performed for each participant on the smoothed images. Task-
related blood oxygen level-dependent signal changes were esti-
mated for each task condition. Six head movement regressors
were also modelled, in addition to the instruction screen, single
button presses during rest and blocks during which partici-
pants performed a wrong condition for the motor task. For
the regions of interest, we used peaks identiﬁed in the analyses
of the task-speciﬁc main effect. Only data from the ﬁrst two
visits were used to avoid biasing the peak by the sites that
contributed three visits. The 2-back versus 1-back contrast
(VWM) and the complexity (complex4 simple) and speed
(fast4 slow) contrasts (SFM) were included in the compensa-
tion model. Brain signals were extracted from task-network
regions of interest and included in the model as possible com-
pensator variables; associated performance was included as the
corresponding behavioural variable.
Resting state functional MRI data were analysed using two
complementary connectivity analysis techniques: seed-region
based correlation (functional connectivity) and dynamic
causal modelling (DCM; effective connectivity) (Friston et al.,
2003). For the functional connectivity analyses, seed-based
analysis was used to identify temporal correlations (or func-
tional connectivity) between activity within a priori selected
regions in the left and right dorsolateral prefrontal cortex
(DLPFC) (cognitive) (Owen et al., 2005) and the left primary
motor network (motor) and activity within every voxel across
the whole brain (for further details, see Kloppel et al., 2015).
Signal values for signiﬁcant correlations were extracted and
included in our model as compensators. For the effective
connectivity analyses, DCM uses a model-based approach to
examine brain connectivity, measuring the directed effects of
activity in one region on another region. Regions for the net-
work models were derived from the baseline task-functional
MRI analyses (Kloppel et al., 2015). As such, both structural
brain volume and behavioural measures support our original
model in that they follow a concave-down trajectory of
changes over time, but several of the putative compensator
variables displayed a signiﬁcant cubic rather than quadratic
longitudinal trajectory. We suggest, however, that even in
these cases, these examples partly fulﬁl our criteria for com-
pensation due to the concave-down pattern occurring in the
latter stage. Ultimately, we recommend expanding our theor-
etical model of compensation to capture greater complexity in
the brain activity trends.
All biologically plausible directed connections between ﬁve
regions within the cognitive network and seven regions within
the motor network were modelled (Supplementary material).
Compensation model
As illustrated in Fig. 1, the main components of compensation
are a performance outcome (Y), an activation signal compen-
sator (C), and brain volume (X), which are tracked over time.
The time metric for the longitudinal analysis represents a
Huntington’s disease-appropriate transformation of age
(denoted as Age). Huntington’s disease is caused by a CAG
expansion, and the longer the expansion the earlier the motor
onset (Ross and Tabrizi, 2011). To account for this acceler-
ation, age can be adjusted for CAG expansion, which enables
the tracking of individuals with various CAG expansions on
the same time metric (i.e. age adjusted for CAG expansion; see
below for details). The vertical axis represents scores on meas-
ures standardized to have equal means at the ﬁrst observation.
Three phases are depicted spanning Age0 to Age

1 (Phase 1),
Age1 to Age

2 (Phase 2), and beyond Age

2 (Phase 3). For
Huntington’s disease, brain volume is expected to steadily de-
crease over time regardless of phase, which is consistent with
research ﬁndings (Paulsen et al., 2014). Phase 1 is compensa-
tion, where brain activation increases in reaction to brain de-
terioration, and the increased activation causes performance to
be maintained. In Phase 2, disease effects start to overwhelm
compensation, which results in an activation plateau and the
initiation of performance deterioration. Phase 3 shows relent-
less disease effects with brain activation starting to decrease
and performance deterioration accelerating.
The right panel of Fig. 2 shows approximations that result
when quadratic polynomial regression models are ﬁtted to the
data of the left panel. The performance and compensator
curves are approximated by a quadratic curve; whereas brain
volume is approximated by a linear curve. Under a polynomial
regression analysis, the right panel curve patterns suggest cri-
teria for determining if empirical data are consistent with
Huntington’s disease compensation. Using the polynomial
curves as our touchstone, we propose that the following
three conditions are necessary for consistency with compensa-
tion: (i) brain volume (X) shows a linear decrease over time (as
patients age); (ii) the performance variable (Y) has a concave-
down pattern over time; and (iii) the compensator variable (C)
also has a concave-down pattern over time.
When regression models are used for the analysis, the above
conditions translate into the following statistical results.
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Condition 1: a statistically signiﬁcant negative linear trend for
X. Condition 2: a signiﬁcant negative quadratic trend for Y
(the quadratic regression coefﬁcient must have a negative sign
for the curve to be concave-down). Condition 3: a signiﬁcant
negative quadratic trend for C. If the previous conditions hold,
then we also expect a slower downward acceleration for C
relative to Y at some late-phase point, but this is not formally
tested. The difference in acceleration is difﬁcult to test because
its effect will be small relative to testing against the null of the
three conditions (it is common for statistical power to be
greater when testing if a regression coefﬁcient is statistically
different from 0 then testing the difference of coefﬁcients)
(Dupont and Plummer, 1998). Therefore, the difference in ac-
celeration is not formally included as a condition. A rigorous
evaluation of the conditions involves the possibility that each
variable could have a simpler curve or more complex curve
than proposed in the conditions. Therefore, evaluation of each
condition will involve ﬁtting linear, quadratic, and cubic trend
models.
Statistical analysis
The compensation analysis involved three correlated variables
(X, Y, C) measured on the same individuals over time. To
account for the correlation between variables and within
time, multivariate linear mixed models (MLMMs) (Verbeke,
2000) were used for the analysis (multivariate refers to mul-
tiple outcome variables). The analysis involved one brain
volume composite variable (X), eight candidate performance
variables (Y), and 61 candidate compensator variables (C).
The performance motor variables were multiplied by 1, so
that smaller values on all performance variables represented
greater deterioration, which was consistent with the X and C
variables.
Because of the well-known relationship between the timing
of motor onset and CAG expansion (Lee et al., 2012), it was
important to account for CAG expansion. An approach that
has proved useful in Huntington’s disease research (Paulsen
et al., 2014) is to adjust age for CAG expansion by means
of the CAG-Age Product (CAP) transformation (Ross et al.,
2014). The time metric of the analysis was
CAP ¼ age  ðCAG 35:5Þ, which is similar to the disease
burden score of Penney et al. (1997), and adjusts age for the
acceleration due to CAG expansion. To facilitate estimation
and testing with the MLMMs, CAP was centred using
M ¼ 320 (the approximate mean among participants and re-
peated measures) and scaled by S ¼ 60 [the approximate
standard deviation (SD)], which we denote as
CAP ¼ ðCAP 320Þ=60. Variables were on different scales,
and to facilitate comparison, each variable was standardized
based on its own vector of scores (among participants and
repeated measures). The standardization meant that change
over time for each variable was expressed in standard devi-
ation units (for all variables, smaller scores indicated greater
deterioration).
A rigorous evaluation of the compensation conditions re-
quires that a trajectory simpler than the hypothesized trajec-
tory be ruled out, and a trajectory more complex also be ruled
out. For example, the second condition hypothesizes a quad-
ratic trajectory for Y, and a rigorous demonstration would rule
out the simpler linear trajectory and the more complex cubic
trajectory. For this reason, we ﬁt linear, quadratic, and cubic
polynomial models for the ﬁrst three compensation conditions.
Let ZðvÞij denote the standardized score for the v
th variable
(v ¼ X;Y;C) for the ith participant (i ¼ 1; . . . ;Nv) and the jth
time point (j ¼ 1; . . . ;ni). Then the single-variable equation of
the most complex cubic MLMM is,
ZðvÞij ¼ aðvÞ þ aðvÞi þ b vð Þ1 ðCAPÞ þ b vð Þ2 CAPð Þ2 þ b vð Þ3 CAPð Þ3
þ gðvÞxTi þ eðvÞij
ð1Þ
where the Greek letters indicate ﬁxed effects for the vth vari-
able, aðvÞ is the ﬁxed intercept, aðvÞi is the random intercept, and
eðvÞij is random error. For an individual outcome, the two
random variables are assumed to be uncorrelated, and each
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Figure 1 Compensation model and polynomial approximation. Left: The compensation model. Right: The polynomial approximation.
Dashed vertical lines denote phases of compensation. Age* is age-adjusted for CAG expansion.
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Figure 2 An example of compensation in the secondary motor cortex. Standardized empirical data (circles and thin lines) and fitted
curves (thick lines) with 95% bootstrap confidence intervals, for three sets of variables. The first column shows the disease load variable, brain
volume composite; the column shows the behavioural variable, and the third column shows the compensator variable Total motor score was
multiplied by 1 prior to standardization, and smaller values indicated greater deterioration. PMC = premotor cortex; PPC = posterior parietal
cortex.
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is assumed to be normally distributed with zero-mean and
non-zero variance. xi is a vector of dummy variables for sex,
education (ISCED level 3 or 4 or 5), and site (London, Leiden,
Paris, Vancouver), with associated ﬁxed effects vector g. The
quadratic model omits the cubic term and the linear model
additionally omits the quadratic term. When the MLMM in-
volves two or three outcome variables—bivariate with ZðXÞij
and ZðYÞij , and trivariate with Z
ðXÞ
ij , Z
ðYÞ
ij , Z
ðCÞ
ij —the random
effects are allowed to correlate. (Details of specifying the bi-
variate and trivariate MLMMs are provided in Thiebaut et al.,
2002; Long, 2012; Gregory et al., 2017.)
The MLMM was estimated using restricted maximum like-
lihood (REML). When there are missing data (as in this ana-
lysis), REML yields unbiased estimates under the assumption
that the missing data mechanism is ignorable. Testing was
performed using the Wald statistic (z-ratio), which was the
ratio of a regression coefﬁcient to its standard error (SE). To
account for multiple testing, the false discovery rate (FDR) q-
value was computed, along with the Wald P-value. Adjustment
was made based on the grouping of variables explained below.
Statistical signiﬁcance was deﬁned by the criterion q50:05
(except for the ﬁrst set of tests).
Because of a varying number of candidate variables, a three-
step strategy of statistical testing was used, beginning with a
univariate LMM for X only, then bivariate MLMMs with X
and Y, and ﬁnally trivariate MLMMs with X, Y, and C. In the
ﬁrst step, the univariate model was estimated for brain volume
in isolation (not considering Y and C) because it was the only
candidate X variable. Consistent with the ﬁrst compensation
condition, the null hypothesis of H0 : b
ðXÞ
3 ¼ 0 (zero cubic co-
efﬁcient) was tested with the cubic polynomial model,
H0 : b
ðXÞ
2 ¼ 0 (zero quadratic coefﬁcient) was tested with the
quadratic model, and H0 : b
ðXÞ
1 ¼ 0 was tested with the linear
model. Signiﬁcance was determined by P-values for these tests.
As the results below show, testing revealed that a linear model
for the brain volume composite was sufﬁcient, and the quad-
ratic and cubic models for X were no longer considered.
In the second step, each Y variable was modelled along with
the X variable in a bivariate MLMM, with a linear curve
speciﬁed for X. The series of tests for linear, quadratic, and
cubic terms was conducted for Y. FDR adjustment was based
on the group of eight Y variables. The statistically signiﬁcant Y
variables (q50:05) were then used in the trivariate MLMMs
(non-signiﬁcant variables were not considered further). As the
results below show, testing revealed that a quadratic model
was sufﬁcient for every Y, and only the quadratic model was
carried forward.
The third step involved estimation of a trivariate MLMM
with X (linear curve), Y (quadratic curve), and C. The series of
tests for linear, quadratic, and cubic terms was conducted for
C. The previous two steps resulted in ﬁltering out several Y
variables, so that the trivariate models consisted of a subset of
59 Y and C variable combinations. The FDR adjustment was
based on the group of C variables with a common Y variable.
For each Y variable in the analysis, there were several asso-
ciated compensator variables. For example, the Y variable of
global cognitive composite had 28 associated connectivity vari-
ables. The FDR correction was performed for the group of
compensators for each Y variable. So, in this case, the FDR
correction was applied to the 28 tests in the trivariate analysis.
Regarding the informal (i.e. not tested) difference in acceler-
ation between the Y and C variables, we had to allow for the
possibility of a signiﬁcant cubic effect or a signiﬁcant quadratic
effect (see ‘Results’ section). Therefore, the instantaneous rate
of change at the late point of CAP ¼ 420 was computed, with
this value being the 0.95 percentile of the CAP scores. The
instantaneous rate of change is the ﬁrst derivative of the sig-
niﬁcant polynomial model at CAP = 420.
Results
Compensation conditions
Compensation Condition 1: linear increase of struc-
tural disease load (brain volume)
Brain volume composite (X) was examined testing the
linear ﬁxed effect coefﬁcient, the quadratic coefﬁcient, and
the cubic coefﬁcient in separate models. The linear model
for brain volume had a coefﬁcient estimate (SE) of
b^
ðXÞ
1 = 1.0271 (0.0509), and the Wald test was statistically
signiﬁcant (P50.0001). The quadratic model for brain
volume was not statistically signiﬁcant, b^
ðXÞ
2 = 0.0289
(0.0276), P = 0.2963, and the cubic model also was not
signiﬁcant, b^
ðXÞ
3 ¼ 0:0263 0:0158ð Þ;P ¼ 0:0954. The results
provide strong evidence that brain volume change can be
characterized by a decreasing linear trend over CAP.
Therefore, the linear curve for brain volume was used in
all subsequent analyses.
Compensation Condition 2: non-linear decrease of
cognitive and motor behavioural variables
Behavioural variables for the cognitive and motor net-
works, for both task (Y) and resting state (C) analyses
were combined in our second analysis (Table 1). Table 1
displays the results for all behavioural variables from the
bivariate MLMM (modelled with linear change in brain
volume). UHDRS-TMS, Q-Motor Speeded Tapping, the
global cognitive composite and two conditions of the
SFM task (slow simple and slow complex) had signiﬁcant
negative quadratic coefﬁcients (concave-down trend)
q’s50.05, whereas the remaining variables had signiﬁcant
negative linear (decreasing) trends. The behavioural vari-
ables showing consistency with our model conditions,
UHDRS-TMS, Q-Motor Speeded Tapping, the global cog-
nitive composite and the most signiﬁcant condition from
the SFM task (slow simple), were included in the next
step of trivariate modelling.
Compensation Condition 3: concave-downward
trend for compensator variables
Based on the analyses for compensation Condition 2, the
following pairings of behavioural and compensatory vari-
ables were used in our trivariate analysis (brain volume com-
posite was always an additional variable in the model). For
the motor network: UHDRS-TMS and Q-Motor Speeded
Tapping were separately used as behavioural variables
with DCM connectivity parameters as compensators; SFM
Longitudinal compensation in premanifest Huntington’s disease BRAIN 2018: Page 7 of 11 | 7
Downloaded from https://academic.oup.com/brain/advance-article-abstract/doi/10.1093/brain/awy122/4998819
by Universitaetsbibliothek Bern user
on 31 May 2018
performance was used as the behavioural variable with SFM
task-based brain activity as compensator. For the cognitive
network: global cognitive composite was used as the behav-
ioural variable for seed-based functional connectivity and
DCM connectivity parameters. Table 2 shows the statistic-
ally signiﬁcant results for the test of polynomial coefﬁcients
in the separate trivariate models (full results are shown in
Supplementary Table 1).
Compensation in the cognitive and motor networks
Table 2 shows there were two variable combinations con-
sistent with the conditions of compensation, i.e. where both
behaviour and compensator variables showed a quadratic
trend: global cognitive composite combined with the left
DLPFC to right DLPFC connection and the right DLPFC
to left DLPFC connection. For the remaining combinations,
the compensator variables, i.e. the brain connectivity meas-
ures showed signiﬁcant cubic trends. The last column of
Table 2 shows that all the cubic trends did have a decreasing
instantaneous slope for the late CAP value (CAP = 420),
except for the connection between the left DLPFC and
right lateral occipital cortex. A visualization of the results
is shown in Fig. 2; the circles connected by thin lines indicate
the individual data points for each sampled time point, and
the red curves indicate the ﬁtted polynomials from the
models with 95% bootstrapped conﬁdence intervals. The
ﬁrst row depicts one compensator variable with a quadratic
trend (right DLPFC to left DLPFC connection), and the
second and third rows show two compensator variables
with cubic trends. The other cubic trends were similar,
except for the connection between the left DLPFC and
right lateral occipital cortex (Table 2).
Discussion
In the current study we have empirically investigated lon-
gitudinal compensation in premanifest Huntington’s disease
Table 2 Significant trivariate model results
Y variable C variable Linear Quadratic Cubic Slope
UHDRS Total Motor Score Effective connection from left PMC
to right PMC
0.0179 (0.0639) 0.0612 (0.0502) 0.0850 (0.0384)* 0.4365 (0.2033)
UHDRS Total Motor Score Effective connection from right PMC
to left PMC
0.0160 (0.0632) 0.0884 (0.0497) 0.1244 (0.0375)** 0.6785 (0.1987)
UHDRS Total Motor Score Effective connection from right PMC
to left PPC
0.0205 (0.0725) 0.0303 (0.0561) 0.0951 (0.0422)* 0.3619 (0.2233)
Q-Motor Speeded Tapping Effective connection from left PMC
to right PMC
0.0143 (0.0639) 0.0591 (0.0504) 0.0846 (0.0387)* 0.4358 (0.2053)
Q-Motor Speeded Tapping Effective connection from right PMC
to left PMC
0.0205 (0.0634) 0.0858 (0.0499) 0.1229 (0.0379)** 0.6750 (0.2008)
Q-Motor Speeded Tapping Effective connection from right PMC
to left PPC
0.0202 (0.0726) 0.0293 (0.0564) 0.0921 (0.0428)* 0.3536 (0.2262)
Global Cognitive Composite Effective connection from left
DLPFC to right DLPFC
0.0167 (0.0682) 0.1504 (0.0523)* 0.0639 (0.0397) 0.4376 (0.1709)
Global Cognitive Composite Effective connection from right
DLPFC to left DLPFC
0.0719 (0.0684) 0.1769 (0.0515)** 0.0787 (0.0389) 0.4643 (0.1685)
Global Cognitive Composite Functional connection between left
DLPFC and right lateral occipital
cortex
0.0522 (0.0725) 0.0486 (0.0561) 0.1315 (0.0413)* 0.3060 (0.2174)
q-values are not provided for the slope because it is not used for inference (only description); *q50.05, **q50.01, ***q50.001. PMC = premotor cortex; PPC = posterior parietal
cortex.
Table 1 Performance variable (Y) results based on the bivariate linear mixed model
Y variable Linear Quadratic Cubic Slope n Obs
UHDRS Total Motor Score 0.6530 (0.0739)*** 0.2168 (0.0491)*** 0.0035 (0.0354) 1.2721 (0.1583) 107 288
Q-Motor Speeded Tapping 0.4852 (0.0759)*** 0.1195 (0.0536)* 0.0553 (0.0391) 0.8300 (0.1720) 107 288
Global Cognitive Composite 0.4268 (0.0696)*** 0.1711 (0.0458)*** 0.0449 (0.0292) 0.9095 (0.1471) 107 288
Speeded Tapping (slow, simple) 0.1902 (0.0892)* 0.1729 (0.0702)* 0.0992 (0.0529) 0.7432 (0.2402) 96 193
Speeded Tapping (fast, simple) 0.1692 (0.0668)** 0.0369 (0.0535) 0.0316 (0.0409) 0.2870 (0.1835) 96 193
Speeded Tapping (slow, complex) 0.2718 (0.0826)*** 0.1375 (0.0637)* 0.0558 (0.0488) 0.7133 (0.2194) 96 193
Speeded Tapping (fast, complex) 0.1616 (0.0774)* 0.0225 (0.0619) 0.0608 (0.0471) 0.2335 (0.2120) 96 193
Verbal Working Memory (d-prime) 0.2078 (0.0892)* 0.0039 (0.0682) 0.0223 (0.0532) 0.2199 (0.2285) 97 217
q-values are not provided for the slope because it is not used for inference (only description); *q50.05, **q50.01, ***q50.001.
Results for the performance variables from the bivariate MLMM (modelled with linear change in brain volume composite). The table lists the estimated polynomial trend coefficient
estimate (SE), and significant level. and associated inferential statistics, along with the sample size and total number of observations (Obs). Significant results are highlighted in bold.
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using an explicit model of compensation. Using a novel
framework previously proposed (Gregory et al., 2017) we
examined longitudinal compensation in cognitive and
motor networks in Huntington’s disease with up to
3 years of data. Our model integrated progressive brain
volume loss, task and resting state functional MRI derived
markers of compensation, and cognitive and motor behav-
iour to test for the presence of compensation across three
sequential phases of neurodegenerative disease progression.
We hypothesized that compensation would be evidenced by
linear decline in brain volume, but a non-linear concave-
down pattern of both brain activity and behaviour, with
brain activity eventually declining at a slower rate and
maintaining normal behaviour. Consistent with our
model, we found that these compensation conditions were
fulﬁlled by combinations of variables involving the global
cognition and the cognitive network, and partially fulﬁlled
by combinations of variables that involved the motor net-
work and both clinical and quantitative motor perform-
ance. More speciﬁcally, global cognition was temporarily
maintained by increased effective connectivity between the
left and right dorsolateral prefrontal cortex, such that the
connections (as compensators) showed signiﬁcant concave-
down patterns, while both clinical UHDRS Total Motor
Score and quantitative motor behaviour were supported
by increased connectivity between the left and right pre-
motor cortex. However, in the latter case, the concave-
down patterns occurred within signiﬁcant cubic trends,
i.e. later than proposed in our model and so only partially
fulﬁlling our prespeciﬁed criteria for compensation. As
such, our original model requires some revision to allow
for connectivity effects to be delayed relative to behaviour
effects.
Compensation primarily confers advantage to neurode-
generative patients by facilitating maintenance of normal
behaviour in the presence of pathology. Accordingly, our
conceptualization of compensation was realized across both
the motor and cognitive networks at differing levels. We
primarily identiﬁed evidence of compensation in the cogni-
tive network using effective or directed connectivity param-
eters between the left and right DLPFC, with the global
cognitive composite as the behavioural variable. Thus, we
provide evidence that connectivity was increased between
the left and right hemispheres in the presence of ongoing
decline in brain volume. Cognitive deﬁcits are prominent in
Huntington’s disease gene carriers many years prior to
onset (Paulsen et al., 2008; Tabrizi et al., 2012, 2013).
However, given that some gene carriers present with
more motor signs, others more cognitive signs, the exact
nature of the mechanisms underlying these deﬁcits is un-
known. The DLPFC is a region that is commonly involved
in higher-order cognitive processing, including tasks that
are components of our global cognitive composite, such
as the Stroop Word Reading and the Symbol Digit
Modality tests. We previously tested compensation in
Huntington’s disease using a simpliﬁed cross-sectional ap-
proach, focusing solely on participants with the highest
structural disease load. We showed that individuals with
higher disease load displayed increased activity within the
right parietal cortex and increased connectivity between the
right DLPFC and regions within the left hemisphere to
maintain cognitive performance (Kloppel et al., 2015). It
is important to stress that in the current study we explicitly
model the longitudinal trajectory of compensation, with no
a priori knowledge regarding patterns of longitudinal com-
pensation for either cognitive or motor networks. However,
it is nonetheless compelling that we have identiﬁed a pat-
tern of longitudinal compensation in the cognitive network
involving the DLPFC. Collectively, these ﬁndings suggest
that the DLPFC plays a role in maintaining cognitive func-
tion in pre-HD that is consistent over time. It is particularly
interesting that the strongest effect was seen in the connec-
tion from the right to left DLPFC, compatible with the
right-sided compensation effects that we identiﬁed previ-
ously and indicating that the DLPFC may be an important
target area for investigation in terms of improving cognitive
deﬁcits in Huntington’s disease gene carriers.
A similar pattern of compensation was also evident in the
motor network for connections between the left and right
premotor cortex and the right premotor and parietal cor-
tices when using both the clinically-based UHDRS Total
Motor Score and the Q-Motor behavioural measure of
Speeded Tapping. However, these patterns did not com-
pletely fulﬁl our hypothesized criteria for compensation as
the compensating variables, i.e. connectivity parameters,
showed a concave-down pattern as part of a cubic rather
than quadratic trend. We have postulated previously that
for compensation to be present, both performance and
compensatory brain activity should follow a concave-
down trajectory over time, such that both will peak and
gradually deteriorate over time but with the trajectory for
brain activity slower to progress than that of behaviour to
maintain normal levels of behaviour (Gregory et al., 2017).
We accept that brain activity could simply represent
Huntington’s disease-related pathology independent of the
compensatory process, but believe that we have shown that
our model reﬂects functional MRI activity as an index of
compensation. However, it is possible that brain activity
may follow a more complex trajectory compared to that
of behaviour and structural disease load. Patterns of change
in brain activity may vary across different brain regions,
due to variability in the timing of the cellular effects of the
huntingtin gene mutation. In the case of the motor net-
work, for example, motor deﬁcits in Huntington’s disease
become evident around the point of disease onset and as
such are used in the process of clinical diagnosis. There is
considerable evidence to suggest volumetric differences in
primary and premotor regions of the motor cortex in
Huntington’s disease when compared to controls
(Kassubek et al., 2004; Wolf et al., 2009; Dogan et al.,
2013). This is supported by new work using structural
DCM that investigates longitudinal change in grey matter
cortical volume over a 7-year period in premanifest and
recently diagnosed early-Huntington’s disease gene carriers
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(in preparation). Here, motor brain regions including bilat-
eral primary, premotor and supplementary motor undergo
a fairly rapid period of accelerated atrophy in the years
shortly after clinical diagnosis; this is in contrast to other
brain regions, e.g. in the frontal lobe where atrophy is more
pronounced in the premanifest stages. It is therefore pos-
sible that motor brain activity is more variable during the
premanifest stages of disease, leading to what appears to be
a delayed compensatory effect and made evident as a cubic
trend in Fig. 2. The trajectory of brain activity does appear
to become more consistent as disease progresses, however,
with all three examples in Fig. 2 indicating that around the
point where the CAP score reaches 400, there is deterior-
ation in brain activity for both networks that occurs at a
slower pace than behavioural change.
Overall, the results provide evidence that compensation
does not follow one canonical course and as a central con-
cept may incorporate a number of compensatory processes
that act concurrently. Furthermore, it is also possible that
our approach will not necessarily identify all conceivable
patterns of compensation such as those that are only ap-
parent under certain cognitive conditions and that other
models of reserve and compensation as discussed in the
healthy ageing literature may be more appropriate. In the
current study, we have adapted our original model
(Gregory et al., 2017), to consider the possibility that
each type of variable may have a simpler or more complex
curve than the theoretical conditions we initially proposed
necessary to justify compensation. As such, both structural
brain volume and behavioural measures support our ori-
ginal model in that they follow a concave-down trajectory
of changes over time, but several of the putative compen-
sator variables displayed a signiﬁcant cubic rather than
quadratic longitudinal trajectory. We suggest, however,
that even in these cases, these examples partly fulﬁl our
criteria for compensation due to the concave-down pattern
occurring in the latter stage. Ultimately, we recommend
expanding our theoretical model of compensation to cap-
ture greater complexity in the brain activity trends.
Conceptualizing longitudinal compensation presents a
major challenge for the neurodegeneration ﬁeld. It can be
characterized by a number of differing models of cognitive
reserve or compensation, which focus on an increase in
activation, as modelled here, a decrease in activation or
simply a slowing of deterioration. Furthermore, compensa-
tory and disease effects may not vary sufﬁciently to be de-
tectable over a relatively short period. Our approach here
has been to develop and test a model encompassing both
within- and between-participant changes. As our data
spanned 3 years, longitudinal compensation patterns were
largely inferred from between-participant differences.
Differences in individual rates of disease progression may
obscure some of the longitudinal changes in compensation.
It will be optimal to collect a long time series (over many
years or indeed decades) so that compensation processes
can be observed within-participant, but resources for such
a study would be considerable. Nonetheless, we have
developed an operational model of compensation that can
now be used in this way to test for both cross-sectional and
longitudinal compensation in other neurodegenerative dis-
ease with similar patterns to Huntington’s disease.
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